scorecardresearch
Friday, August 22, 2025
TopicMelanoma

Topic: melanoma

Phase 2 trial of Moderna-Merck’s personalised cancer vaccine shows positive results

Treatment with Moderna’s experimental mRNA vaccine in combination with Merck’s immunotherapy technology reduced risk of cancer recurrence or death by 44%, the companies said.

After Covid, mRNA vaccine for cancer? US researchers report initial success against melanoma

Mice treated with the mRNA vaccine, delivered like ones for Covid, showed reduction in tumours & long-term immune memory, says study by Tufts University researchers published in PNAS.

Sunscreen won’t save dark-skinned people from melanoma

The notion that regular application of sunscreen will reduce an already extremely rare occurrence is nonsensical.

On Camera

Swraj Paul was the original NRI powerbroker. Helped Indira’s return, shaped India Inc

When he was asked why he was so loud in his criticisms of Indian industry when his purpose could be better served by a shrewder approach, he said, “Because I am a Punjabi, not a Marwari”.

New insolvency frameworks to shorter timelines, how 2025 amendment bill proposes to transform IBC

New bill aims to fix key issues with IBC 2016, including delays & patchy implementation, and protect creditors, with window for genuine promoters to retain control of their companies.

Indian firm joins hands with US manufacturer to locally develop all-terrain vehicles for armed forces

Under joint venture, JSW Sarbloh Motors will indigenise and manufacture TX range ATVs in Chandigarh. The first India-assembled unit is expected by early 2026.

War of IAF, PAF doctrines: As Pakistan obsesses over numbers, India embraces risk, wins

Now that both IAF and PAF have made formal claims of having shot down the other’s aircraft in the 87-hour war in May, we can ask a larger question: do such numbers really matter?